JP2005533061A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533061A5
JP2005533061A5 JP2004512749A JP2004512749A JP2005533061A5 JP 2005533061 A5 JP2005533061 A5 JP 2005533061A5 JP 2004512749 A JP2004512749 A JP 2004512749A JP 2004512749 A JP2004512749 A JP 2004512749A JP 2005533061 A5 JP2005533061 A5 JP 2005533061A5
Authority
JP
Japan
Prior art keywords
heteroatoms
independently selected
ring
groups
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004512749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533061A (ja
JP4489586B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018401 external-priority patent/WO2003105846A1/en
Publication of JP2005533061A publication Critical patent/JP2005533061A/ja
Publication of JP2005533061A5 publication Critical patent/JP2005533061A5/ja
Application granted granted Critical
Publication of JP4489586B2 publication Critical patent/JP4489586B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004512749A 2002-06-13 2003-06-11 細菌感染を治療するジャイレースおよび/またはトポイソメラーゼiv阻害剤としての2−ウレイド−6−ヘテロアリール−3h−ベンゾイミダゾール−4−カルボン酸誘導体および関連化合物 Expired - Fee Related JP4489586B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38866502P 2002-06-13 2002-06-13
US42907702P 2002-11-26 2002-11-26
PCT/US2003/018401 WO2003105846A1 (en) 2002-06-13 2003-06-11 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections

Publications (3)

Publication Number Publication Date
JP2005533061A JP2005533061A (ja) 2005-11-04
JP2005533061A5 true JP2005533061A5 (cg-RX-API-DMAC7.html) 2006-07-20
JP4489586B2 JP4489586B2 (ja) 2010-06-23

Family

ID=29740049

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004512749A Expired - Fee Related JP4489586B2 (ja) 2002-06-13 2003-06-11 細菌感染を治療するジャイレースおよび/またはトポイソメラーゼiv阻害剤としての2−ウレイド−6−ヘテロアリール−3h−ベンゾイミダゾール−4−カルボン酸誘導体および関連化合物

Country Status (17)

Country Link
US (2) US7727992B2 (cg-RX-API-DMAC7.html)
EP (1) EP1511482B1 (cg-RX-API-DMAC7.html)
JP (1) JP4489586B2 (cg-RX-API-DMAC7.html)
KR (1) KR101052433B1 (cg-RX-API-DMAC7.html)
CN (1) CN1674898A (cg-RX-API-DMAC7.html)
AT (1) ATE345132T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003245442B2 (cg-RX-API-DMAC7.html)
CA (1) CA2489128C (cg-RX-API-DMAC7.html)
DE (1) DE60309701T2 (cg-RX-API-DMAC7.html)
ES (1) ES2277088T3 (cg-RX-API-DMAC7.html)
IL (1) IL165715A (cg-RX-API-DMAC7.html)
MX (1) MXPA04012628A (cg-RX-API-DMAC7.html)
NO (1) NO20050099L (cg-RX-API-DMAC7.html)
PL (1) PL374191A1 (cg-RX-API-DMAC7.html)
RU (1) RU2333208C2 (cg-RX-API-DMAC7.html)
TW (1) TWI282335B (cg-RX-API-DMAC7.html)
WO (1) WO2003105846A1 (cg-RX-API-DMAC7.html)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100590859B1 (ko) * 1999-09-14 2006-06-19 삼성전자주식회사 교환기 시스템의 기능 시험방법
AU2003245442B2 (en) * 2002-06-13 2009-02-05 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8193352B2 (en) 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US20060223849A1 (en) 2005-03-14 2006-10-05 Mjalli Adnan M Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
WO2007056330A1 (en) * 2005-11-07 2007-05-18 Vertex Pharmaceuticals Incorporated Benzimidazole derivatives as gyrase inhibitors
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
EA017648B1 (ru) 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
AR069599A1 (es) * 2007-12-07 2010-02-03 Vertex Pharma Forma cristalina de 1- etil-1-3-(5-(5- fluoropiridin -3-il)-7- (pirimidin-2-il)-1h-benzo (d) imidazol -2-il) urea
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2552893B1 (en) 2010-03-31 2014-10-29 Actelion Pharmaceuticals Ltd. Antibacterial isoquinolin-3-ylurea derivatives
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
CA2801274C (en) 2010-06-01 2021-06-15 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
JP6085829B2 (ja) 2011-01-14 2017-03-01 スペロ トリネム, インコーポレイテッド ピリミジンジャイレースおよびトポイソメラーゼiv阻害剤
MX341342B (es) * 2011-01-14 2016-08-17 Vertex Pharma Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
KR101882172B1 (ko) 2011-01-14 2018-07-26 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
US8481552B2 (en) * 2011-01-14 2013-07-09 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
ES2576298T3 (es) 2011-06-20 2016-07-06 Vertex Pharmaceuticals Incorporated Ésteres de fosfato de inhibidores de girasa y topoisomerasa
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
SG11201606332PA (en) 2014-02-03 2016-09-29 Spero Gyrase Inc Antibacterial combinations comprising polymyxin
EP3104707B1 (en) * 2014-02-12 2020-07-15 Albert Einstein College of Medicine, Inc. Treatment of h. pylori infections using mtan inhibitors
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
RU2019133662A (ru) 2017-03-24 2021-04-26 Тайсо Фармасьютикал Ко., Лтд. Производное 2(1h)-хинолинона
US20200345637A1 (en) * 2018-01-19 2020-11-05 Aiviva Biopharma, Inc. Suspension compositions of multi-target inhibitors
JP7730803B2 (ja) 2019-07-17 2025-08-28 サミット (オックスフォード) リミティド リジニラゾールの調製方法およびその結晶形態
WO2021126118A1 (en) * 2019-12-20 2021-06-24 Anadolu Üni̇versi̇tesi̇ Synthesis of 2-(substitutedphenyl)-5-(substitutedheteroaryl)- 1h-benzimidazole derivatives and investigation of their biological effects
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
US12220421B2 (en) 2021-09-09 2025-02-11 The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Inhibitors of C. difficile spore germination
NL2033609B1 (en) * 2022-11-24 2024-05-30 Innes John Centre DNA Gyrase Inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803429D0 (en) * 1988-02-15 1988-03-16 Fujisawa Pharmaceutical Co Imidazole compounds processes for preparation thereof & pharmaceutical composition comprising same
CA2028530A1 (en) * 1989-11-21 1991-05-22 Christian Hubschwerlen Substituted pyrimidobenzimidazole derivatives
AU675680B2 (en) * 1992-10-14 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
DE4344074A1 (de) * 1993-12-23 1995-06-29 Hoechst Schering Agrevo Gmbh Bicyclische Heteroarylverbindungen, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung als Safener
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
ES2124167B1 (es) * 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
GB9911594D0 (en) * 1999-05-19 1999-07-21 Smithkline Beecham Plc Novel compounds
PL362691A1 (en) * 2000-12-15 2004-11-02 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
AU2003245442B2 (en) * 2002-06-13 2009-02-05 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7569591B2 (en) 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
CA2489128A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
CA2513463A1 (en) Gyrase inhibitors and uses thereof
CA2577758A1 (en) Gyrase inhibitors and uses thereof
JP5474768B2 (ja) 臨床的に潜伏性の微生物を殺傷するための4−(ピロリジン−1−イル)キノリン化合物の使用
US9382226B2 (en) Aldosterone synthase inhibitors
JP2006528677A5 (cg-RX-API-DMAC7.html)
JP2009514894A5 (cg-RX-API-DMAC7.html)
JP5153329B2 (ja) (r/s)リファマイシン誘導体、その調製、および医薬組成物
JP5977344B2 (ja) ジャイレースおよびトポイソメラーゼ阻害剤のリン酸エステル
US20100093691A1 (en) Topical formulations
CA2433197A1 (en) Gyrase inhibitors and uses thereof
JP2007514782A5 (cg-RX-API-DMAC7.html)
EP2738169B1 (en) Oxazolidinone compounds and their uses in preparation of antibiotics
KR20150027922A (ko) 신규한 항진균성 피리디닐하이드라자이드 유도체
JP2022521339A (ja) グラム陽性菌に対して向上された抗菌活性を提供する組成物およびその使用
SE0203304D0 (sv) Novel Coumpounds
CN108003155A (zh) 抗菌的高哌啶基取代的3,4二氢-1h[1,8]萘啶酮类
JP2002509858A5 (cg-RX-API-DMAC7.html)
JP2003507361A5 (cg-RX-API-DMAC7.html)
JP2007519685A5 (cg-RX-API-DMAC7.html)
CA2554070A1 (en) Macrolides with antiinflammatory activity
RU2008137145A (ru) Производные хромана
JP2025515098A5 (cg-RX-API-DMAC7.html)
SE0102640D0 (sv) Novel compounds
JP2008519848A5 (cg-RX-API-DMAC7.html)